STOCK TITAN

[Form 4] Microchip Technology Inc Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Matthew W. Chapman, a director of Microchip Technology Inc. (MCHP), reported a sale of 10,000 shares of the issuer's common stock on 08/25/2025 at a reported price of $68.255 per share. After the sale, Mr. Chapman beneficially owned 30,665 shares, held directly. The Form 4 indicates no derivative transactions and was signed on behalf of the reporting person by an attorney-in-fact on 08/27/2025.

Matthew W. Chapman, amministratore di Microchip Technology Inc. (MCHP), ha venduto 10.000 azioni del patrimonio netto dell'emittente il 25/08/2025 al prezzo dichiarato di $68,255 per azione. Dopo la vendita, il sig. Chapman possedeva utilmente 30.665 azioni, detenute direttamente. Il Modulo 4 segnala l'assenza di operazioni su derivati ed è stato firmato per conto della persona che rende la comunicazione da un procuratore il 27/08/2025.

Matthew W. Chapman, director de Microchip Technology Inc. (MCHP), informó la venta de 10.000 acciones del capital común del emisor el 25/08/2025 a un precio reportado de $68,255 por acción. Tras la venta, el Sr. Chapman poseía de forma beneficiosa 30.665 acciones, mantenidas directamente. El Formulario 4 indica que no hubo transacciones con derivados y fue firmado en nombre de la persona informante por un apoderado el 27/08/2025.

Matthew W. Chapman은 Microchip Technology Inc. (MCHP)의 이사로서 발행회사의 보통주 10,000주를 2025-08-25에 주당 보고가격 $68.255에 매각했다고 보고했습니다. 매각 후 Chapman 씨는 직접 보유 형태로 30,665주를 실질적으로 보유하고 있었습니다. 양식(Form 4)은 파생상품 거래가 없음을 표시하며, 보고인을 대신해 대리인이 2025-08-27에 서명했습니다.

Matthew W. Chapman, administrateur de Microchip Technology Inc. (MCHP), a déclaré la vente de 10 000 actions ordinaires de l'émetteur le 25/08/2025 au prix déclaré de 68,255 $ par action. Après la vente, M. Chapman détenait à titre bénéficiaire 30 665 actions, détenues directement. Le formulaire 4 indique l'absence d'opérations sur dérivés et a été signé au nom de la personne déclarante par un mandataire le 27/08/2025.

Matthew W. Chapman, Direktor von Microchip Technology Inc. (MCHP), meldete den Verkauf von 10.000 Stammaktien des Emittenten am 25.08.2025 zu einem gemeldeten Preis von $68,255 pro Aktie. Nach dem Verkauf besaß Herr Chapman wirtschaftlich 30.665 Aktien, unmittelbar gehalten. Das Formular 4 weist keine Derivatgeschäfte aus und wurde im Namen der meldenden Person von einem Bevollmächtigten am 27.08.2025 unterzeichnet.

Positive
  • None.
Negative
  • Director sale of 10,000 shares on 08/25/2025 at $68.255 per share, reducing the reporting person's holdings

Insights

TL;DR: Director sale reported; small direct shareholding remains and no derivatives were involved.

The Form 4 documents a straightforward open-market sale by a company director: 10,000 common shares disposed at $68.255 each, leaving 30,665 shares beneficially owned directly. The filing shows no derivative positions or additional compensatory transactions. For investors, this is a routine Section 16 disclosure that documents insider liquidity but does not, by itself, indicate broader corporate changes.

Matthew W. Chapman, amministratore di Microchip Technology Inc. (MCHP), ha venduto 10.000 azioni del patrimonio netto dell'emittente il 25/08/2025 al prezzo dichiarato di $68,255 per azione. Dopo la vendita, il sig. Chapman possedeva utilmente 30.665 azioni, detenute direttamente. Il Modulo 4 segnala l'assenza di operazioni su derivati ed è stato firmato per conto della persona che rende la comunicazione da un procuratore il 27/08/2025.

Matthew W. Chapman, director de Microchip Technology Inc. (MCHP), informó la venta de 10.000 acciones del capital común del emisor el 25/08/2025 a un precio reportado de $68,255 por acción. Tras la venta, el Sr. Chapman poseía de forma beneficiosa 30.665 acciones, mantenidas directamente. El Formulario 4 indica que no hubo transacciones con derivados y fue firmado en nombre de la persona informante por un apoderado el 27/08/2025.

Matthew W. Chapman은 Microchip Technology Inc. (MCHP)의 이사로서 발행회사의 보통주 10,000주를 2025-08-25에 주당 보고가격 $68.255에 매각했다고 보고했습니다. 매각 후 Chapman 씨는 직접 보유 형태로 30,665주를 실질적으로 보유하고 있었습니다. 양식(Form 4)은 파생상품 거래가 없음을 표시하며, 보고인을 대신해 대리인이 2025-08-27에 서명했습니다.

Matthew W. Chapman, administrateur de Microchip Technology Inc. (MCHP), a déclaré la vente de 10 000 actions ordinaires de l'émetteur le 25/08/2025 au prix déclaré de 68,255 $ par action. Après la vente, M. Chapman détenait à titre bénéficiaire 30 665 actions, détenues directement. Le formulaire 4 indique l'absence d'opérations sur dérivés et a été signé au nom de la personne déclarante par un mandataire le 27/08/2025.

Matthew W. Chapman, Direktor von Microchip Technology Inc. (MCHP), meldete den Verkauf von 10.000 Stammaktien des Emittenten am 25.08.2025 zu einem gemeldeten Preis von $68,255 pro Aktie. Nach dem Verkauf besaß Herr Chapman wirtschaftlich 30.665 Aktien, unmittelbar gehalten. Das Formular 4 weist keine Derivatgeschäfte aus und wurde im Namen der meldenden Person von einem Bevollmächtigten am 27.08.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CHAPMAN MATTHEW W

(Last) (First) (Middle)
C/O MICROCHIP TECHNOLOGY INCORPORATED
2355 WEST CHANDLER BOULEVARD

(Street)
CHANDLER AZ 85224-6199

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 S 10,000 D $68.255 30,665 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Deborah L. Wussler, as Attorney-in-Fact 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Matthew W. Chapman report on Form 4 for MCHP?

He reported a sale of 10,000 common shares on 08/25/2025 at a price of $68.255 per share.

How many MCHP shares does the reporting person own after the reported transaction?

The Form 4 shows the reporting person beneficially owned 30,665 shares following the sale.

Were any derivative securities reported in this Form 4 for MCHP?

No. The filing shows no derivative securities were acquired, disposed of, or beneficially owned.

Who signed the Form 4 and when was it signed?

The form was signed by Deborah L. Wussler, as Attorney-in-Fact on 08/27/2025.

Does this Form 4 indicate the reporting person is an officer or director of MCHP?

Yes. The filing identifies the reporting person as a Director of Microchip Technology Inc.
Microchip Technology Inc.

NASDAQ:MCHP

MCHP Rankings

MCHP Latest News

MCHP Latest SEC Filings

MCHP Stock Data

37.00B
528.30M
2.1%
104.52%
5.42%
Semiconductors
Semiconductors & Related Devices
Link
United States
CHANDLER